Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dysplastic Nevus Syndrome × Pharmaceutical Preparations × Dermatologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 4 Neoplasm Metastasis 1 Hereditary Sensory and Autonomic Neuropathies 1 Dysplastic Nevus Syndrome 1

Interventions

Dermoscopy 2 pembrolizumab 1 Transdermal Patch 1 Sutures 1 Standard of Care 1 Practice Guidelines as Topic 1 Pharmaceutical Preparations 1 Nivolumab 1 Genome 1 Diagnostic Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06599619 2026-01-26

Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi

University of Pittsburgh

Dysplastic Nevus Syndrome, Melanoma, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡